NCT00710710 Open, Randomized Phase II Trial to Investigate the Efficacy and Safety of the PLK-1 Inhibitor BI 2536 in Patients With Advanced, Unresectable Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00708214 BIBW 2992 and Letrozole in Hormonoresistant Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00706628 A Multi-centre 3-arm Randomised Phase II Trial of BIBF 1120 Versus BIBW 2992 Versus Sequential Administration of BIBF 1120 and BIBW 2992 in Patients With Hormone-resistant Prostate Cancer Status COMPLETED Phase PHASE2
NCT00701766 BI 2536 Infusional Treatment in Patients Over 60 Years of Age With Refractory or Relapsed Acute Myeloid Leukaemia Status COMPLETED Phase PHASE2
NCT00699699 Observational Non-Interventional Study With Spiriva Respimat in COPD Patients Status COMPLETED Phase N/A
NCT00696020 Combination of Orally Inhaled BI1744CL/Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease ( COPD) Status COMPLETED Phase PHASE2
NCT00681863 Open-label Extension Study of Pramipexole in the Treatment of Children and Adolescents With Tourette Syndrome Status TERMINATED Phase PHASE3
NCT00680186 Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp Venous Thromboembolism (VTE) Status COMPLETED Phase PHASE3
NCT00673452 A Study Comparing Duloxetine and Placebo in the Treatment of Fibromyalgia Status COMPLETED Phase PHASE4
NCT00666757 A Study Comparing Duloxetine to Other Antidepressants in the Treatment of Severe Depression Status COMPLETED Phase PHASE4
NCT00666653 Effects of a Dopamine Agonist on Pharmacodynamics of Levodopa in Parkinson's Disease Status COMPLETED Phase PHASE1
NCT00662792 Efficacy and Safety Comparison of Tiotropium Daily + Salmeterol Daily or Twice Daily Versus Tiotropium Daily in Patients With COPD Status COMPLETED Phase PHASE3
NCT00662740 Tiotropium/Salmeterol Inhalation Powder (Spiriva Handihaler and Salmeterol Polyethylene (PE) Capsule) in Chronic Obstructive Pulmonary Disease (COPD) Status TERMINATED Phase PHASE3